BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, March 29, 2024
Home
»
Newsletters
» BioWorld Asia
BioWorld Asia
July 2, 2008
View Archived Issues
EU Drug Development Slowdown Due to Biotech Complexity?
BRUSSELS, Belgium - There is a slowdown in the volume of useful new drugs on the European market, and biotech is in part to blame, according to the leading European pharmaceutical industry association. (BioWorld International)
Read More
Alizyme, Norgine Team Up in $67M Marketing Deal
Read More
Blood Vessel Growth Blocker Could Be Used to Starve Tumors
Read More
Short of Money and Time, Ardana Biosciences Dies
Read More
Patent Infringement Claim Filed Against Oxford Biomedica
Read More
Oxford Profs Found Celleron to Scope Tumor Sensitivity
Read More
Immutep Reports Positive Results from LAG-3 Immunotherapy
Read More
Ascenion Adds Protectimmun to its Investment Portfolio
Read More
Other News To Note
Read More